$ABBV.d
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's...
$564.92
$257
14
$331.74
ABBVIE INC. Metrics
Metric
Show % of Total
Market Cap by Network
Key Facts
Type
Fees
Fees
Market Data
Active Addresses
Transfer Count
Transfer Volume
Tokens
Primary Market
Investment
Fees
Fees
Service Providers
Custodian
Legal Identifier
Legal & Regulatory
U.S. Securities Act Reg. S Exemption
Segregation
Remote
Insurance
Fees
Fees
Fees
Fees
Fees
Holders
View detailed token
holder breakdowns
Sign up for a free account to get access to breakdowns of which investor addresses hold an RWA across blockchain networks.
RWA.xyzAll Rights Reserved